Carol Pena
Inventor
Stats
- 0 US patents issued
- 6 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 0 US Patents Issued
- 6 US Applications Filed
- 65 Total Citation Count
- Jan 31, 2017 Most Recent Filing
- Jun 3, 2003 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
CURAGEN CORPORATION | 1
| 2003
|
BAYER HEALTHCARE PHARMACEUTICALS INC. | 2
| 2016
|
BAYER PHARMA AKTIENGESELLSCHAFT | 2
| 2016
|
Inventor Addresses
Address | Duration |
---|---|
Basking Ridge, NJ, US | Feb 15, 18 - Dec 19, 19 |
New Haven, CT | Mar 10, 05 - Jan 05, 06 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 5 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 1 |
C07H: | SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS | 1 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2019/0382,839 | 2019 | COPANLISIB BIOMARKERS | 1 |
10406162 | 2019 | Substituted 2,3-dihydroimidazo[1,2-C]quinazoline-containing combinations | 3 |
2019/0038,632 | 2019 | COPANLISIB BIOMARKERS | 5 |
2018/0055,851 | 2018 | SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE-CONTAINING COMBINATIONS | 9 |
2018/0042,929 | 2018 | USE OF SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINES | 12 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.